ANEMIA AND RHEUMATOID ARTHRITIS
Keywords:
anemia, rheumatoid arthritis
Abstract
The represented analysis of literature is dedicated to the problem of anemia development at rheumatoid arthritis (RA), which develops in 36-65% of cases. It is accompanied hypoxia of tissues and can, on the one hand lead to damage of various organs and systems, and with another – to deterioration of a clinical course and the prognosis of the patient. Pathogenetic mechanisms of an anaemia in RА: change of a metabolism of iron, life shortening of erythrocyte, or their inadequate production a bone marrow, a role of proinflammatory cytokines, drugs and genetic factors. We investigated the role of those medicines, which is used in the treatment of this pathology and improved quality of life.
Downloads
Download data is not yet available.
References
1. Коваленко В.М. Хвороби системи кровообігу: динаміка та аналіз / В.М. Коваленко, В.М Корнаць-кий // Аналітично-статистичний посібник. – 2008. – С. 66–79.
2. Wolfe F. Anemia and renal function in patients with rheumatoid arthritis / F. Wolfe, K. Michaud // J. Rheumatol. – 2006. – № 8. – Р.1467–1468.
3. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R . Peeters, М. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р.162–168.
4. Doyle M.K. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality / М.К. Doyle, M.U. Rahman, C. Han // J. Rheumatol. – 2008. – № 3. – Р.380–386.
5. Nikolaisen C. The differentiation of anaemia in rheumatoid arthritis: parameters of iron-deficiency in an Indian rheumatoid arthritis population / С. Nikolaisen, Y. Figenschau, J.C. Nossent // Rheumatol Int. – 2008. – № 6. – Р.507–511.
6. Ravindran V. Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian pa-tients / V. Ravindran, S. Jain, D.S. Mathur // Rheumatol Int. – 2006. – № 12. – Р.1091–1095.
7. Agrawal S. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / S. Agrawal, R. Misra, A. Aggrawal // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
8. Vreugdenhil G. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / G. Vreugdenhil, A.W. Wognum, H.G. van Eijk, A.J. Swaak // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
9. Kuruvilla J. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor / J. Ku-ruvilla, H.A. Leitch, L.M. Vickars // Eur J Haematol. – 2003. – № 5. – Р. 396–398.
10. Vucelić V. Combined megaloblastic and immunohemolytic anemia associated--a case report / V. Vucelić, V. Stancić, M. Ledinsky // Acta Clin Croat. – 2008. – № 4. – Р.239–243.
11. Соломатина М.А. Анемия при хронических заболеваниях / М.А. Соломатина, В.К. Альпидовский // Вестник Российского университета дружбы народов. – 1999. – № 1. – С. 36–38.
12. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
13. Matsumura I. Pathogenesis of anemia of chronic disease / I. Matsumura, Y. Kanakura // Nippon Rinsho. – 2008. – № 3. – Р. 535–539.
14. Weiss G. Pathogenesis and treatment of anaemia of chronic disease / G. Weiss // Blood Rev. – 2002. – № 2. – Р. 87–96.
15. Maciejewski J.Р. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha // J.Р Maciejewski, С. Selleri, T. Sato // J. Clin Invest. – 1995. – №96. – Р. 1085–1092.
16. Rafferty S.P. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line / S.P. Rafferty, J.B. Domachowske, H.L. Malech // Blood. – 1996. – № 88. – Р. 1070–1078.
17. Li H. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS / Н. Li, M.J. Rose, L. Tran, J. Zhang, L.P. Miranda, С.А. James, B.J. Sasu // J. Pharmacol Toxicol Methods. – 2009. – № 179. – Р. 171–180.
18. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
19. Pigeon C. A new mouse liver specific protein homologous to human antibacterial peptid hepcidin is overexpressed during iron overload / С. Pigeon, G. Ilyin, В. Courselaud // J. Biol. Chem. – 2001. – № 276. – Р. 7811–7819.
20. Kemna E. Time_course analisis of hepcidin, serum iron and plasma cytokine levels in humans injected with LPS / Е. Kemna, Р. Pickkers, Е. Nemeth // Blood. – 2005. – № 5. – Р. 1864–1866.
21. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin / M.D. Knutson, М. Oukka, L.M. Koss [et al.] // Proc Natl Acad Sci U S A. – 2005. – № 102. – Р. 1324-1328.
22. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008 Mar; 57(3):374-82. Chaston T. Evidence for differential effects of hepcidin in macrophages and in-testinal epithelial cells / Т. Chaston, В. Chung, М. Mascarenhas [et al.] // Gut. – 2008. – № 57. – Р. 374–382.
23. Lang F. Mechanisms and significance of eryptosis / F. Lang, K.S. Lang, Р.А. Lang // Antioxid Redox Signal. – 2006. – № 8. – Р. 1183–1192.
24. Moldawer L.L. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo / L.L. Moldawer, М.А. Marano, Н. Wei // FASEB J. – 1989. – № 3. – Р. 1637–1643.
25. Weiss G. Anemia of Chronic Disease / G. Weiss, L.T Goodnough // New. Eng. J. Med. – 2005. – № 10. – Р. 1011–1023.
26. Вуд Мари Э. Секреты гематологии и онкологии / Мари Э.Вуд, Пол А.Банн [пер. с англ.].- Москва : Бином, 1997. –38 c.
27. Baer A.N. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis / A.N. Baer, E.N. Dessypris, S.B. Krantz // Semin Arthritis Rheum. – 1990. – № 4. – Р. 209–223.
28. Smith M.A. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythro-poietin and of interleukin 1 production by marrow macrophages // М.А. Smith, S.M. Knight, P.J. Maddi-son // Ann Rheum Dis. – 1992. – № 6. – Р. 753–757.
29. Kullich W. Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis / W. Kullich, F. Niksic, K. Burmucic // Z Rheumatol. – 2002. – № 61. – Р. 568–576.
30. Zhu Y. The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis / Y. Zhu, D. Ye, Z. Huang // Zhonghua Xue Ye Xue Za Zhi. – 2000. – № 21. – Р. 587–590.
31. Means R.T. Recent developments in the anemia of chronic disease / R.T. Means // Curr. Hematol. Rep. – 2003. – № 2. – Р. 116–121.
32. Papadaki H.A. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy / Н.А. Papadaki, H.D. Kritikos, V. Valatas // Blood. – 2002. – № 100. – Р. 474–482.
33. Glossop J.R. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes / J.R. Glossop, P.T. Dawes, A.B. Hassell // J Rheumatol. – 2005. – № 9. – Р. 1673–1678.
34. Segal R., Baumoehl Y., Elkayam O. (2004) Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int, 24(1): 14–19.
35. Nakazaki S. Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis / S. Nakazaki, Т. Murayama // Ryumachi. – 2001. – № 6. – Р. 929–937.
36. Bolla G. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis / G. Bolla, Р. Disdier, J.R. Harle // Clin Rheumatol. – 1993. – № 4. – Р. 535–537.
37. Lim A.Y. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years / A.Y. Lim, K.Gaffney, D.G. Scott // Rheumatology – 1995. – № 8. – Р. 1051–1055.
38. Hirshberg B. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis / В. Hirshberg, M.Muszkat, O.Schlesinger // Postgrad Med J. – 2000. – № 902. – Р. 787–789.
39. Nurmohamed М.Т. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis / М.Т. Nurmohamed, М.Soesan, М.Н. van Oers // Rheumatology. – 2000. – № 12. – Р. 1431–1433.
40. Yan A. Gold induced marrow suppression: a review of 10 cases / А. Yan, P. Davis // J Rheumatol. – 1990. – № 1. – Р. 47–51.
41. Azathioprine-induced suicidal erythrocyte death / С. Geiger, M. Föller, K.R. Herrlinger [et al.] // Inflamm Bowel Dis. – 2008. – № 8. – Р. – 1027–1032.
42. Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plas-modium falciparum malaria / А. Ballal, A. Saeed, P. Rouina [et al.] // Ann Hematol. – 2009. – № 5. – Р. 411–415.
43. Giordano N. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferriox-amine / N. Giordano, A. Fioravanti, S. Sancasciani // Br Med J. – 1984. – № 6450. – Р. 961–962.
44. Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid ar-thritis / А. Davidson, М.В. Van der Weyden [et al.] // Br Med J. – 1984. – № 289. – Р. 648–650.
45. Saravana S. Anemia of chronic disease in patients with rheumatoid arthritis--use of zinc protoporphyrin (ZPP) levels / S. Saravana, A. Rai // J Rheumatol. 1990. – № 2. – Р. 446.
46. Garrett S. Zinc protoporphyrin and iron-deficient erythropoiesis / S. Garrett, M. Worwood // Acta Hae-matol. – 2004. – № 91. – Р. 21–25.
47. Hastka J. Zinc protoporphyrin in anemia of chronic disorders / J. Hastka, J.J.Lasserre, A. Schwarzbeck // Blood. – 1993. – № 81. – Р. 1200–1204.
48. Margetic S. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis / S. Margetic, E. Topic, D.F Ruzic // Clin Chem Lab Med. – 2005. – № 3. – Р. 326–331.
49. Chijiwa Т. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indi-cators for anaemia / Т. Chijiwa, К.Nishiya, К.Hashimoto // Clin Rheumatol. – 2001. – № 5. – Р. 307–313.
50. Doyle M.К. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials / М.К. Doyle, M.U. Rahman, C. Han // Semin Arthritis Rheum. – 2009. – № 2. – Р.123–131. Epub 2008.
51. Dufour C. Etanercept as a salvage treatment for refractory aplastic anemia / С. Dufour, R. Giacchino, P. Ghezzi // Pediatr Blood Cancer. – 2009. – № 4. – Р. 522–525.
52. Ortiz Z. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheu-matoid arthritis / Z. Ortiz, В. Shea, М. Suarez Almazor // Cochrane Database Syst Rev. – 2008. – № 2.
53. Harten Р. Reducing toxicity of methotrexate with folic acid / Р. Harten // Z Rheumatol. – 2005. – № 5. – Р. 353–358.
54. Morgan S.L. Methotrexate in rheumatoid arthritis: folate supplementation should always be given / S.L. Morgan, J.E. Baggott, G.S. Alarcón // BioDrugs. – 1997. – № 3. – Р. 164–175.
55. NKF-K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000 // Am. J. Kidney Dis. — 2001. – № 37. – Р. 182–238.
56. Ruiz-Argüelles G.J. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia / G.J. Ruiz-Argüelles, А. Díaz-Hernández, С. Manzano // Hematology. – 2007. – № 12. – Р. 255–256.
57. Reynoso-Gómez Е. Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients / Е. Reynoso-Gómez, V. Salinas-Rojas, А. Lazo- Langner // Rev Invest Clin. – 2002. – № 54. – Р. 12–20.
58. Weiss G., Goodnough L.T. Anemia of Chronic Disease / G. Weiss, L.T. Goodnough // New. Eng. J. Med. -2005. – № 10. – Р. 1011–1023.
59. Vidal-Alaball J. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency / J. Vi-dal-Alaball, С.С. Butler, К. Hood // Cochrane Database Syst Rev. – 2005. – № 3.
60. Bolaman Z. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study / Z. Bolaman, G. Kadikoylu, V. Yukselen // Clin Ther. – 2003. – № 12. – Р. 3124–3134.
61. Dyjas R. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hor-mones in females with rheumatoid arthritis / R. Dyjas, M. Bułanowski, R. Ficek // Pol Arch Med Wewn. – 2005. – № 114. – Р. 731–737.
62. Arndt U. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin / U. Arndt, J.P. Kaltwasser, R. Gottschalk // Ann Hematol. – 2005. – № 3. – Р. 159–166.
63. Pettersson Т. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis / Т. Pettersson, К. Rosenlöf, Е. Laitinen // Br J Rheumatol. – 2004. – № 6. – Р. 526–529.
64. Gudbjörnsson B. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombi-nant human erythropoietin / В. Gudbjörnsson, R. Hällgren, L. Wide // Ann Rheum Dis. – 1992. – № 6. – Р. 747–752.
65. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R. Peeters, M. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р. 162–168
66. Bhattacharya N. Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy / N. Bhattacharya // Clin Exp Obstet Gynecol. – 2006. – № 33. – Р. 28–33.
67. Burt R.K. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis / R.K. Burt, W. Barr, Y. Oyama // J Rheumatol Suppl. – 2001. – № 64. – Р. 42–48.
68. Lowenthal R.M. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone mar-row transplant / R.M. Lowenthal, D.S. Gill // J Rheumatol. – 2006. – № 33. – Р. 812–813.
2. Wolfe F. Anemia and renal function in patients with rheumatoid arthritis / F. Wolfe, K. Michaud // J. Rheumatol. – 2006. – № 8. – Р.1467–1468.
3. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R . Peeters, М. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р.162–168.
4. Doyle M.K. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality / М.К. Doyle, M.U. Rahman, C. Han // J. Rheumatol. – 2008. – № 3. – Р.380–386.
5. Nikolaisen C. The differentiation of anaemia in rheumatoid arthritis: parameters of iron-deficiency in an Indian rheumatoid arthritis population / С. Nikolaisen, Y. Figenschau, J.C. Nossent // Rheumatol Int. – 2008. – № 6. – Р.507–511.
6. Ravindran V. Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian pa-tients / V. Ravindran, S. Jain, D.S. Mathur // Rheumatol Int. – 2006. – № 12. – Р.1091–1095.
7. Agrawal S. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / S. Agrawal, R. Misra, A. Aggrawal // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
8. Vreugdenhil G. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / G. Vreugdenhil, A.W. Wognum, H.G. van Eijk, A.J. Swaak // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
9. Kuruvilla J. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor / J. Ku-ruvilla, H.A. Leitch, L.M. Vickars // Eur J Haematol. – 2003. – № 5. – Р. 396–398.
10. Vucelić V. Combined megaloblastic and immunohemolytic anemia associated--a case report / V. Vucelić, V. Stancić, M. Ledinsky // Acta Clin Croat. – 2008. – № 4. – Р.239–243.
11. Соломатина М.А. Анемия при хронических заболеваниях / М.А. Соломатина, В.К. Альпидовский // Вестник Российского университета дружбы народов. – 1999. – № 1. – С. 36–38.
12. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
13. Matsumura I. Pathogenesis of anemia of chronic disease / I. Matsumura, Y. Kanakura // Nippon Rinsho. – 2008. – № 3. – Р. 535–539.
14. Weiss G. Pathogenesis and treatment of anaemia of chronic disease / G. Weiss // Blood Rev. – 2002. – № 2. – Р. 87–96.
15. Maciejewski J.Р. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha // J.Р Maciejewski, С. Selleri, T. Sato // J. Clin Invest. – 1995. – №96. – Р. 1085–1092.
16. Rafferty S.P. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line / S.P. Rafferty, J.B. Domachowske, H.L. Malech // Blood. – 1996. – № 88. – Р. 1070–1078.
17. Li H. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS / Н. Li, M.J. Rose, L. Tran, J. Zhang, L.P. Miranda, С.А. James, B.J. Sasu // J. Pharmacol Toxicol Methods. – 2009. – № 179. – Р. 171–180.
18. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
19. Pigeon C. A new mouse liver specific protein homologous to human antibacterial peptid hepcidin is overexpressed during iron overload / С. Pigeon, G. Ilyin, В. Courselaud // J. Biol. Chem. – 2001. – № 276. – Р. 7811–7819.
20. Kemna E. Time_course analisis of hepcidin, serum iron and plasma cytokine levels in humans injected with LPS / Е. Kemna, Р. Pickkers, Е. Nemeth // Blood. – 2005. – № 5. – Р. 1864–1866.
21. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin / M.D. Knutson, М. Oukka, L.M. Koss [et al.] // Proc Natl Acad Sci U S A. – 2005. – № 102. – Р. 1324-1328.
22. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008 Mar; 57(3):374-82. Chaston T. Evidence for differential effects of hepcidin in macrophages and in-testinal epithelial cells / Т. Chaston, В. Chung, М. Mascarenhas [et al.] // Gut. – 2008. – № 57. – Р. 374–382.
23. Lang F. Mechanisms and significance of eryptosis / F. Lang, K.S. Lang, Р.А. Lang // Antioxid Redox Signal. – 2006. – № 8. – Р. 1183–1192.
24. Moldawer L.L. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo / L.L. Moldawer, М.А. Marano, Н. Wei // FASEB J. – 1989. – № 3. – Р. 1637–1643.
25. Weiss G. Anemia of Chronic Disease / G. Weiss, L.T Goodnough // New. Eng. J. Med. – 2005. – № 10. – Р. 1011–1023.
26. Вуд Мари Э. Секреты гематологии и онкологии / Мари Э.Вуд, Пол А.Банн [пер. с англ.].- Москва : Бином, 1997. –38 c.
27. Baer A.N. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis / A.N. Baer, E.N. Dessypris, S.B. Krantz // Semin Arthritis Rheum. – 1990. – № 4. – Р. 209–223.
28. Smith M.A. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythro-poietin and of interleukin 1 production by marrow macrophages // М.А. Smith, S.M. Knight, P.J. Maddi-son // Ann Rheum Dis. – 1992. – № 6. – Р. 753–757.
29. Kullich W. Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis / W. Kullich, F. Niksic, K. Burmucic // Z Rheumatol. – 2002. – № 61. – Р. 568–576.
30. Zhu Y. The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis / Y. Zhu, D. Ye, Z. Huang // Zhonghua Xue Ye Xue Za Zhi. – 2000. – № 21. – Р. 587–590.
31. Means R.T. Recent developments in the anemia of chronic disease / R.T. Means // Curr. Hematol. Rep. – 2003. – № 2. – Р. 116–121.
32. Papadaki H.A. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy / Н.А. Papadaki, H.D. Kritikos, V. Valatas // Blood. – 2002. – № 100. – Р. 474–482.
33. Glossop J.R. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes / J.R. Glossop, P.T. Dawes, A.B. Hassell // J Rheumatol. – 2005. – № 9. – Р. 1673–1678.
34. Segal R., Baumoehl Y., Elkayam O. (2004) Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int, 24(1): 14–19.
35. Nakazaki S. Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis / S. Nakazaki, Т. Murayama // Ryumachi. – 2001. – № 6. – Р. 929–937.
36. Bolla G. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis / G. Bolla, Р. Disdier, J.R. Harle // Clin Rheumatol. – 1993. – № 4. – Р. 535–537.
37. Lim A.Y. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years / A.Y. Lim, K.Gaffney, D.G. Scott // Rheumatology – 1995. – № 8. – Р. 1051–1055.
38. Hirshberg B. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis / В. Hirshberg, M.Muszkat, O.Schlesinger // Postgrad Med J. – 2000. – № 902. – Р. 787–789.
39. Nurmohamed М.Т. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis / М.Т. Nurmohamed, М.Soesan, М.Н. van Oers // Rheumatology. – 2000. – № 12. – Р. 1431–1433.
40. Yan A. Gold induced marrow suppression: a review of 10 cases / А. Yan, P. Davis // J Rheumatol. – 1990. – № 1. – Р. 47–51.
41. Azathioprine-induced suicidal erythrocyte death / С. Geiger, M. Föller, K.R. Herrlinger [et al.] // Inflamm Bowel Dis. – 2008. – № 8. – Р. – 1027–1032.
42. Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plas-modium falciparum malaria / А. Ballal, A. Saeed, P. Rouina [et al.] // Ann Hematol. – 2009. – № 5. – Р. 411–415.
43. Giordano N. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferriox-amine / N. Giordano, A. Fioravanti, S. Sancasciani // Br Med J. – 1984. – № 6450. – Р. 961–962.
44. Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid ar-thritis / А. Davidson, М.В. Van der Weyden [et al.] // Br Med J. – 1984. – № 289. – Р. 648–650.
45. Saravana S. Anemia of chronic disease in patients with rheumatoid arthritis--use of zinc protoporphyrin (ZPP) levels / S. Saravana, A. Rai // J Rheumatol. 1990. – № 2. – Р. 446.
46. Garrett S. Zinc protoporphyrin and iron-deficient erythropoiesis / S. Garrett, M. Worwood // Acta Hae-matol. – 2004. – № 91. – Р. 21–25.
47. Hastka J. Zinc protoporphyrin in anemia of chronic disorders / J. Hastka, J.J.Lasserre, A. Schwarzbeck // Blood. – 1993. – № 81. – Р. 1200–1204.
48. Margetic S. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis / S. Margetic, E. Topic, D.F Ruzic // Clin Chem Lab Med. – 2005. – № 3. – Р. 326–331.
49. Chijiwa Т. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indi-cators for anaemia / Т. Chijiwa, К.Nishiya, К.Hashimoto // Clin Rheumatol. – 2001. – № 5. – Р. 307–313.
50. Doyle M.К. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials / М.К. Doyle, M.U. Rahman, C. Han // Semin Arthritis Rheum. – 2009. – № 2. – Р.123–131. Epub 2008.
51. Dufour C. Etanercept as a salvage treatment for refractory aplastic anemia / С. Dufour, R. Giacchino, P. Ghezzi // Pediatr Blood Cancer. – 2009. – № 4. – Р. 522–525.
52. Ortiz Z. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheu-matoid arthritis / Z. Ortiz, В. Shea, М. Suarez Almazor // Cochrane Database Syst Rev. – 2008. – № 2.
53. Harten Р. Reducing toxicity of methotrexate with folic acid / Р. Harten // Z Rheumatol. – 2005. – № 5. – Р. 353–358.
54. Morgan S.L. Methotrexate in rheumatoid arthritis: folate supplementation should always be given / S.L. Morgan, J.E. Baggott, G.S. Alarcón // BioDrugs. – 1997. – № 3. – Р. 164–175.
55. NKF-K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000 // Am. J. Kidney Dis. — 2001. – № 37. – Р. 182–238.
56. Ruiz-Argüelles G.J. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia / G.J. Ruiz-Argüelles, А. Díaz-Hernández, С. Manzano // Hematology. – 2007. – № 12. – Р. 255–256.
57. Reynoso-Gómez Е. Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients / Е. Reynoso-Gómez, V. Salinas-Rojas, А. Lazo- Langner // Rev Invest Clin. – 2002. – № 54. – Р. 12–20.
58. Weiss G., Goodnough L.T. Anemia of Chronic Disease / G. Weiss, L.T. Goodnough // New. Eng. J. Med. -2005. – № 10. – Р. 1011–1023.
59. Vidal-Alaball J. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency / J. Vi-dal-Alaball, С.С. Butler, К. Hood // Cochrane Database Syst Rev. – 2005. – № 3.
60. Bolaman Z. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study / Z. Bolaman, G. Kadikoylu, V. Yukselen // Clin Ther. – 2003. – № 12. – Р. 3124–3134.
61. Dyjas R. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hor-mones in females with rheumatoid arthritis / R. Dyjas, M. Bułanowski, R. Ficek // Pol Arch Med Wewn. – 2005. – № 114. – Р. 731–737.
62. Arndt U. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin / U. Arndt, J.P. Kaltwasser, R. Gottschalk // Ann Hematol. – 2005. – № 3. – Р. 159–166.
63. Pettersson Т. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis / Т. Pettersson, К. Rosenlöf, Е. Laitinen // Br J Rheumatol. – 2004. – № 6. – Р. 526–529.
64. Gudbjörnsson B. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombi-nant human erythropoietin / В. Gudbjörnsson, R. Hällgren, L. Wide // Ann Rheum Dis. – 1992. – № 6. – Р. 747–752.
65. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R. Peeters, M. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р. 162–168
66. Bhattacharya N. Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy / N. Bhattacharya // Clin Exp Obstet Gynecol. – 2006. – № 33. – Р. 28–33.
67. Burt R.K. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis / R.K. Burt, W. Barr, Y. Oyama // J Rheumatol Suppl. – 2001. – № 64. – Р. 42–48.
68. Lowenthal R.M. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone mar-row transplant / R.M. Lowenthal, D.S. Gill // J Rheumatol. – 2006. – № 33. – Р. 812–813.
How to Cite
Vatutin, M., Kalinkina, N., & Smyrnova, G. (1). ANEMIA AND RHEUMATOID ARTHRITIS. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (19), 76-82. Retrieved from https://periodicals.karazin.ua/medicine/article/view/6943
Issue
Section
Reviews
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
